National Advisory Committee on Immunization

National Advisory Committee on Immunization
Name	National Advisory Committee on Immunization
Abbreviation	NACI
Formation	1964
Type	Advisory committee
Purpose	Immunization guidance
Headquarters	Ottawa, Ontario
Region served	Canada
Language	English, French
Parent organization	Public Health Agency of Canada

National Advisory Committee on Immunization is an expert advisory body that provides guidance on vaccine use, vaccine safety, and immunization practices in Canada. It issues evidence-informed recommendations that influence policy within provincial and territorial immunization programs, collaborating with organizations such as the Public Health Agency of Canada, Health Canada, Royal Society of Canada, and academic institutions including the University of Toronto and the Université de Montréal. The committee interacts with international bodies like the World Health Organization, the Centers for Disease Control and Prevention, and the European Centre for Disease Prevention and Control.

History

The committee was established in the 1960s amid expansion of vaccine programs influenced by events such as the Polio vaccine campaigns and global efforts led by the World Health Organization and the United Nations Children's Fund. Throughout the 1970s and 1980s it engaged with issues emerging from the Smallpox eradication era, the introduction of routine vaccines such as the Measles vaccine and the Diphtheria, tetanus and pertussis vaccine; in the 1990s it responded to challenges posed by the Hepatitis B vaccine rollout and the dengue of public debate around immunization safety exemplified by controversies in other jurisdictions like the Wakefield affair in the United Kingdom. During the 2000s and 2010s the committee advised on implementation of newer vaccines including the Human papillomavirus vaccine, the Pneumococcal conjugate vaccine, and the Rotavirus vaccine, while coordinating with agencies such as the Canadian Institutes of Health Research and provincial ministries like Ontario Ministry of Health and British Columbia Ministry of Health.

Organization and Membership

Membership is composed of clinicians, epidemiologists, immunologists, pediatricians, public health physicians, and pharmacologists drawn from institutions including the McGill University, the University of British Columbia, the McMaster University, and the University of Alberta. Appointments are often made in consultation with federal entities like the Public Health Agency of Canada and professional bodies such as the Canadian Medical Association, the Canadian Paediatric Society, and the College of Family Physicians of Canada. The committee has standing subcommittees and working groups that include representatives from regulatory agencies like Health Canada and liaise with laboratories such as the National Microbiology Laboratory and academic centers like the Children's Hospital of Eastern Ontario Research Institute.

Mandate and Responsibilities

The committee's mandate includes developing vaccine recommendations, assessing immunization schedules, and advising on post-marketing vaccine safety in coordination with regulatory frameworks administered by Health Canada and surveillance systems like the Canadian Adverse Events Following Immunization Surveillance System. It provides guidance that informs legal and programmatic frameworks used by provincial and territorial bodies including the Alberta Health Services and the Québec Ministry of Health. The committee also contributes to national preparedness and response planning alongside organizations such as the Public Health Agency of Canada, the Canadian Red Cross, and the Royal Canadian Mounted Police during public health emergencies and pandemics similar to responses shaped globally by the 2009 H1N1 pandemic and the COVID-19 pandemic.

Advisory Processes and Evidence Review

Recommendations are developed through systematic review of clinical trials, observational studies, pharmacoepidemiology data, and immunogenicity research from centers such as the Canadian Cancer Trials Group and the Institut national de santé publique du Québec. The committee employs methodologies aligned with standards from organizations like the Cochrane Collaboration, the GRADE Working Group, and the National Institutes of Health for assessment of benefit-risk and certainty of evidence. It convenes expert panels, solicits input from stakeholder groups including the Canadian Immunization Committee and the Canadian Public Health Association, and reviews post-market surveillance data from sources such as provincial vaccine registries and the Vaccine Adverse Event Reporting System-style systems used internationally.

Recommendations and Policy Impact

NACI's guidance has influenced introduction and prioritization of vaccines including the Influenza vaccine, the Human papillomavirus vaccine, and the COVID-19 vaccine in Canada, shaping immunization schedules adopted by provincial programs like Manitoba Health and Nova Scotia Health. Its recommendations affect procurement decisions involving manufacturers such as GlaxoSmithKline, Pfizer, Moderna, and Sanofi, and inform public communication strategies coordinated with agencies like the Public Health Agency of Canada and provincial health authorities. NACI guidance is often cited in clinical practice by specialists affiliated with the Royal College of Physicians and Surgeons of Canada and in policy documents produced by the Canadian Agency for Drugs and Technologies in Health.

Notable Decisions and Controversies

The committee has made notable decisions during crises, including interim advice during the 2009 H1N1 pandemic and rapid guidelines during the COVID-19 pandemic regarding dose intervals and prioritization that intersected with policies from jurisdictions like Ontario and Quebec. Controversies have arisen over interpretation of limited evidence, supply-constrained allocation decisions involving contracts with manufacturers, and public communication amid vaccine safety debates similar to those in the Wakefield affair and disputes seen in the United Kingdom and United States. The committee's independence and transparency have been scrutinized by stakeholder organizations including the Canadian Medical Association, academic commentators from universities such as the University of Calgary, and media outlets covering public health policy.

Category:Health in Canada